Cephalon: FTC's Challenge To Patent Settlements
Last week, the Federal Trade Commission ("FTC" or "commission") brought the latest in a series of challenges to patent settlements between brand and generic firms in the pharmaceutical industry....To view the full article, register now.
Already a subscriber? Click here to view full article